YU237579A - Process for obtaining basic ethers - Google Patents

Process for obtaining basic ethers

Info

Publication number
YU237579A
YU237579A YU02375/79A YU237579A YU237579A YU 237579 A YU237579 A YU 237579A YU 02375/79 A YU02375/79 A YU 02375/79A YU 237579 A YU237579 A YU 237579A YU 237579 A YU237579 A YU 237579A
Authority
YU
Yugoslavia
Prior art keywords
chr
compound
atoms
alkyl
general formula
Prior art date
Application number
YU02375/79A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of YU237579A publication Critical patent/YU237579A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
YU02375/79A 1978-09-30 1979-09-20 Process for obtaining basic ethers YU237579A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782842759 DE2842759A1 (de) 1978-09-30 1978-09-30 Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
YU237579A true YU237579A (en) 1983-02-28

Family

ID=6051039

Family Applications (1)

Application Number Title Priority Date Filing Date
YU02375/79A YU237579A (en) 1978-09-30 1979-09-20 Process for obtaining basic ethers

Country Status (11)

Country Link
EP (1) EP0009683B1 (fr)
JP (1) JPS5551043A (fr)
AT (1) ATE4420T1 (fr)
AU (1) AU526323B2 (fr)
CA (1) CA1136635A (fr)
DE (2) DE2842759A1 (fr)
ES (1) ES484525A1 (fr)
HU (1) HU178648B (fr)
IL (1) IL58328A0 (fr)
YU (1) YU237579A (fr)
ZA (1) ZA795181B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095115A1 (fr) * 1982-05-26 1983-11-30 Bayer Ag Ethers diphényliques substitués
FR2645019A1 (fr) * 1989-03-30 1990-10-05 Fournier Innovation Synergie
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US6297239B1 (en) 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD9565A (fr) *
US2765307A (en) * 1953-02-11 1956-10-02 Rohm & Haas Hydroxyamines
GB787308A (en) * 1955-02-25 1957-12-04 Ferrosan Ab Substituted aminopropiophenones
US3833603A (en) * 1970-04-09 1974-09-03 Bayer Ag 1-(alpha,alpha-disubstituted 4-phenoxy-benzyl)imidazoles
IE40911B1 (en) * 1974-04-11 1979-09-12 Schering Ag Imidazole derivatives and process for their manufacture
DE2523565A1 (de) * 1975-05-28 1977-04-07 Merck Patent Gmbh Araliphatische stickstoffverbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0009683A1 (fr) 1980-04-16
AU526323B2 (en) 1983-01-06
ES484525A1 (es) 1980-06-16
DE2966050D1 (en) 1983-09-15
IL58328A0 (en) 1979-12-30
ATE4420T1 (de) 1983-08-15
ZA795181B (en) 1980-12-31
HU178648B (en) 1982-06-28
DE2842759A1 (de) 1980-04-10
JPS5551043A (en) 1980-04-14
CA1136635A (fr) 1982-11-30
EP0009683B1 (fr) 1983-08-10
AU5126579A (en) 1980-04-17

Similar Documents

Publication Publication Date Title
FR2398056A1 (fr) Thioethers basiques et leur procede de preparation
PH18468A (en) Chephalosporin intermediates and their preparations
AU526323B2 (en) Basic ethers
FR2401148A1 (fr) Procede de preparation de 1-amino-3-aryloxy-2-propanols
EP0135062A3 (en) Cyclohexyldioxane
IL46707A (en) 3-phenylbutane-1,3-diol and 3-phenyl-3-hydroxybutyric acid derivatives, processes for their preparation, and compositions containing them
PT80993A (fr) Procede de preparation d'un derive de 1-(aminophenyl)-2-amino- -athanone
PL238641A1 (en) Process for preparing novel derivatives of 3-chloropregnane
FR2411181A1 (fr) Derives d'imidazole utiles comme intermediaires de preparation du (r)-3-(2-desoxy-ss-d-erythropentofurannosyl)-3,6,7,8-tetrahydro-imidazol-(4,5-d) (1,3)-diazepin-8-ol
FR2416223A1 (fr) Derives de phenylpyrol utilisables comme fongicides
ZA814899B (en) Cycloalkano-thiazolyloxamic acid derivatives,their preparation and therapeutic agents containing these compounds
FR2400508A1 (fr) Derives de l'acide oxanilique, utiles notamment pour ameliorer et controler les symptomes associes a l'asthme, et procede de preparation
DE3060406D1 (en) Antimycotic agent, process for its preparation
ES8106005A1 (es) Procedimiento para la obtencion de derivados de la rifamici-na-s
FR2432517A1 (fr) Procede de preparation d'un derive du thiophene et derive obtenu par ce procede
ZA835663B (en) Process for inverting the configuration of optically active compounds,and optically active intermediates produced in this process
ZA803682B (en) Clavulanic acid derivatives, a process for their preparation and their use
FR2359808A1 (fr) Procede de preparation du phytol
DE3060348D1 (en) Process for the preparation of xanthone derivatives
PL141309B1 (en) Process for preparing novel heterocyclic derivatives of acetic acid
FR2415110A1 (fr) Procede de preparation de derives de l'acide thiazolidin-4-one-acetique
FR2405933A1 (fr) Procede de preparation de s-bentylesters substitues de l'acide n,n-dialkyl-thiocarbamique
ES444194A1 (es) Un procedimiento para la preparacion de acido clavulanico.
JPS56166190A (en) Novel dihydro-as-triazino(5,6-c)quinoline derivative and its manufacture